BOSTON SCIENTIFIC CORP 2019-01.12.27 BOSTON SCIENTIFIC CORP 2019-01.12.27 BOSTON SCIENTIFIC CORP 2019-01.12.27

BOSTON SCIENTIFIC CORP 2019-01.12.27

No trades
See on Supercharts

BSXF analysis



Key facts


Issue date
Nov 12, 2019
Maturity date
Dec 1, 2027
Outstanding amount
‪900.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
0.63% (Fixed)
Yield to maturity
2.74%
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.